Brainsway (BWAY) EBITDA Margin (2018 - 2026)
Brainsway's EBITDA Margin was 15.37% in the quarter ended Jun 30, 2026, up 9.37 percentage points from 6.00% a year earlier and up 1.39 percentage points from the prior quarter.
Powered by 
Analysis
Brainsway (BWAY) EBITDA Margin (2018 - 2026) Analysis & Trends
On a trailing twelve-month basis, Brainsway's EBITDA Margin was 13.62% through Jun 30, 2026, up 7.59 percentage points year-over-year; for the year ended Dec 31, 2025, it was 9.55%, up 4.55 percentage points from the prior year.
- EBITDA Margin has now increased for three consecutive years, though with a five-year change of -14.33 percentage points (years ended Dec 2020 to Dec 2025).
- In earlier years, EBITDA Margin was 5.00% in the year ended Dec 31, 2024 (+19.46 pp), -14.46% in the year ended Dec 31, 2023 (+30.15 pp), -44.61% in the year ended Dec 31, 2022 (-63.36 pp) and 18.74% in the year ended Dec 31, 2021 (-5.13 pp).
- The figure for the quarter ended Jun 30, 2026 marks the highest quarterly EBITDA Margin since the quarter ended Dec 31, 2019.
- Compared with a year earlier, EBITDA Margin has increased for four straight quarters, with an average year-over-year change of +5.43 percentage points over the last eight quarters.
- The best year-over-year quarter for EBITDA Margin over five years was the quarter ended Sep 30, 2023 (a gain of 90.56 percentage points); the worst was the quarter ended Sep 30, 2022 (a drop of 77.19 percentage points).
- Per Business Quant data, BWAY's EBITDA Margin in the three quarters before the quarter ended Jun 30, 2026 was 13.98% (quarter ended Mar 31, 2026), 13.96% (quarter ended Dec 31, 2025) and 10.60% (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 251.30 Bn | 230.45 Bn | 4.88 Bn | 24.20% |
| 2 | Abbott Laboratories | 174.70 Bn | 145.78 Bn | 7.27 Bn | 21.86% |
| 3 | Danaher | 158.94 Bn | 142.76 Bn | 3.61 Bn | 28.51% |
| 4 | Intuitive Surgical | 145.87 Bn | 125.42 Bn | 1.96 Bn | 41.08% |
| 5 | Medtronic | 111.49 Bn | 77.36 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 106.96 Bn | 93.08 Bn | 4.50 Bn | 29.67% |
| 7 | Boston Scientific | 63.62 Bn | 58.63 Bn | 3.85 Bn | 28.17% |
| 8 | Edwards Lifesciences | 50.80 Bn | 34.92 Bn | 1.35 Bn | 31.93% |
| 9 | Becton Dickinson | 49.59 Bn | 46.74 Bn | 2.32 Bn | 24.62% |
| 10 | Brainsway | 527.96 Mn | 264.34 Mn | 12.77 Mn | 15.37% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.37% |
| Mar 31, 2026 | 13.98% |
| Dec 31, 2025 | 13.96% |
| Sep 30, 2025 | 10.60% |
| Jun 30, 2025 | 6.00% |
| Mar 31, 2025 | 6.65% |
| Dec 31, 2024 | 6.86% |
| Sep 30, 2024 | 4.47% |
| Jun 30, 2024 | 6.44% |
| Mar 31, 2024 | 1.70% |
| Dec 31, 2023 | 2.96% |
| Sep 30, 2023 | -0.58% |
| Jun 30, 2023 | -15.86% |
| Mar 31, 2023 | -53.95% |
| Dec 31, 2022 | -69.98% |
| Sep 30, 2022 | -91.14% |
| Jun 30, 2022 | -23.16% |
| Mar 31, 2022 | -16.81% |
| Dec 31, 2021 | -15.12% |
| Sep 30, 2021 | -13.94% |
API Access
Brainsway EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BWAY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "BWAY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BWAY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();